ABUS is already conducting a combination trial of AB-729 with ASMB’s ABI-H0731 that I would characterize as futile insofar as ABI-H0731 is effectively an obsolete compound (#msg-157913492, #msg-162149575).
All told, I would say that ABUS is flailing.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.